Miyazaki T, Sato M, Murata Y, Maeda K, Seo H
Department of Internal Medicine, Nagoya University Branch Hospital, Japan.
Am J Nephrol. 1995;15(1):48-56. doi: 10.1159/000168801.
Rheumatic disorders are common complications in patients on long-term hemodialysis (HD), and abnormalities of collagen metabolism in the musculoskeletal system have been suggested in these patients. Since collagenase, which catalyzes the initial step in the proteolytic degradation of collagen, plays an important role in the metabolism of collagen, the present study investigated whether factor(s) present in the sera from patients on long-term HD stimulates collagenase gene expression in synovial cells. The addition of sera from 8 patients on long-term HD resulted in 1.5- to 4.0-fold increases in the collagenase mRNA level in human synovial cells as compared with that of sera from normal subjects. The collagenase-inducing factor(s) in uremic sera is more than 3,000 D in molecular mass and shows no binding to heparin. Uremic sera also increased stromelysin mRNA, but failed to exert any effect on mRNAs for tissue inhibitor of metalloproteinases and pro alpha 1(I)collagen. Our findings suggest that there exists a factor(s) to enhance degradation of synovial collagen in sera from long-term HD patients.
风湿性疾病是长期血液透析(HD)患者的常见并发症,这些患者的肌肉骨骼系统中已发现存在胶原代谢异常。由于胶原酶催化胶原蛋白蛋白水解降解的起始步骤,在胶原蛋白代谢中起重要作用,因此本研究调查了长期HD患者血清中存在的因子是否刺激滑膜细胞中胶原酶基因的表达。与正常受试者的血清相比,添加8例长期HD患者的血清后,人滑膜细胞中胶原酶mRNA水平增加了1.5至4.0倍。尿毒症血清中的胶原酶诱导因子分子量超过3000 D,且不与肝素结合。尿毒症血清也增加了基质金属蛋白酶-3的mRNA,但对金属蛋白酶组织抑制剂和原α1(I)型胶原蛋白的mRNA没有任何影响。我们的研究结果表明,长期HD患者血清中存在一种增强滑膜胶原降解的因子。